Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Activation of Tyrosine Hydroxylation in Rat Brain in vivo by Chlorpromazine

Abstract

PHENOTHIAZINES and related neuroleptic drugs, such as thioxanthenes, markedly increase the content of homovanillic acid (3-methoxy-4-hydroxyphenylacetic acid) in the brain, especially in the extrapyramidal centres of various animal species. This has raised the question of whether neuroleptic drugs accelerate the synthesis of catecholamines through a feed-back mechanism either as a result of blockade of dopaminergic and noradrenergic receptors or of alteration of the amine storage1–6,16. The present communication shows that in vivo chlorpromazine and related neuroleptics markedly enhance the hydroxylation of tyrosine which seems to be a rate-limiting step in the formation of catecholamines7.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Gey, K. F., and Pletscher, A., J. Pharmacol. Exp. Ther., 145, 337 (1964).

    CAS  PubMed  Google Scholar 

  2. Andén, N. E., Roos, B. E., and Werdinius, B., Life Sci., 3, 149 (1964).

    Article  Google Scholar 

  3. Laverty, R., and Sharman, D. F., Brit. J. Pharmacol., 24, 759 (1965).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Da Prada, M., and Pletscher, A., Experientia, 22, 465 (1966).

    Article  CAS  PubMed  Google Scholar 

  5. Jurio, A. V., Sharman, D. F., and Trajkov, T., Brit. J. Pharmacol., 26, 385 (1966).

    Google Scholar 

  6. Carlsson, C., Denker, S. J., Grimby, G., and Haggendal, J., Scand. J. Clin. Lab. Invest., 17, suppl. 86, 134 (1965).

    Google Scholar 

  7. Levitt, M., Spector, S., Sjoerdsma, A., and Udenfriend, S., J. Pharmacol. Exp. Ther., 148, 1 (1965).

    CAS  PubMed  Google Scholar 

  8. Nagatsu, T., Levitt, M., and Udenfriend, S., J. Biol. Chem., 239, 2910 (1964).

    CAS  PubMed  Google Scholar 

  9. Waalkes, T. P., and Udenfriend, S., J. Lab. Clin. Med., 50, 733 (1957).

    CAS  PubMed  Google Scholar 

  10. Ferri, S., Boll. Ital. Biol. Sper., 40, 1693 (1964).

    CAS  Google Scholar 

  11. Gordon, M. W., Fed. Proc., 24, 301 (1965).

    Google Scholar 

  12. Yuwiler, A., Geller, E., Schapiro, S., and Seater, G. G., Biochem. Pharmacol., 14, 621 (1965).

    Article  CAS  PubMed  Google Scholar 

  13. Shuster, L., and Hannam, R. V., J. Biol. Chem., 239, 3401 (1964).

    CAS  PubMed  Google Scholar 

  14. Satanove, A., J. Amer. Med. Assoc., 191, 263 (1965).

    Article  CAS  Google Scholar 

  15. Greiner, A. C., and Nicolson, G. A., Canad. Med. Assoc. J., 91, 627 (1964).

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Bernheimer, H., and Hornykiewicz, O., Arch. Exp. Path. Pharmak., 251, 135 (1965).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

BURKARD, W., GEY, K. & PLETSCHER, A. Activation of Tyrosine Hydroxylation in Rat Brain in vivo by Chlorpromazine. Nature 213, 732–733 (1967). https://doi.org/10.1038/213732a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/213732a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing